Artop Medical, Inc., "Medopad" Completes $ 26 Million Series A Financing, Hong Kong NWS Holdings LP
Completed $ 26 million Series A round of financing with NWSHold UBS as Hong Kong-based financial advisor Medophad expects to raise $ 120 million in equity financing in coming months after Medopad previously conducted seed Round of financing, financing the amount of 400 million.
The Artificial Intelligence Health Company Medopad announced today.
In a statement issued today, MedVilla CEO Dan Vahdat said there will be more offices around the world, more hires and further partnerships with agencies around the world.
Medopad is an Artificial Intelligence Health company from the United Kingdom, established in 2011. Medopad is committed to using artificial intelligence technology to develop various types of medical and health programs, serving both doctors and patients. For example, working with Apple's Healthkit, Medopad helps hospitals collect patient data on the platform, allowing doctors to remotely look after their patients for real-time information. Medopad products are used by some UK-based HealthServic certified medical institutions and BMI private medical groups in the UK.
Medopad has also developed a leg application sequence LegUlcerCharitiMedepad patients and nurses can upload information and images at any time, including the patient's feelings, the type of medication taken, the level of pain and so on. In addition, there is medication reminder function.
Not only that, Medopad also attempts to solve more complex medical problems using algorithms, such as diagnosing some major illness through early symptoms or identifying misdiagnosed conditions.
The BBC said Sino-British trade volume has risen by 60% since 2010 This week, British Prime Minister Theresa May visit to Britain as Medopad, accompanied by an English business delegation, has signed 15 trade agreements with China , With a total transaction volume of 100 million U.S. dollars, including Tencent, China Resources, GlaxoSmithKline, Peking University, Lenovo, Ping An Good Doctor and Joint Medical Services. Medopad will work with these institutions in medical research, clinical decision-making and patient monitoring Cooperation.